wesentliche Informationen chemische Eigenschaften Zweck Lieferant

(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity) Struktur

(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity)

Bezeichnung:(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity)

CAS-Nr710951-92-1

Englisch Name:(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity)

CBNumberCB32709067

SummenformelC27H33NO7

Molgewicht483.56

MOL-Datei710951-92-1.mol

(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity) physikalisch-chemischer Eigenschaften

Schmelzpunkt 211-214°C
Siedepunkt 598.7±50.0 °C(Predicted)
Dichte 1.38±0.1 g/cm3(Predicted)
storage temp.  Hygroscopic, -20°C Freezer, Under inert atmosphere
Löslichkeit Chloroform (Slightly), Methanol (Slightly)
pka 3.72±0.70(Predicted)
Aggregatzustand Solid
Farbe White to Off-White
Stabilität Hygroscopic

(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity) Chemische Eigenschaften,Einsatz,Produktion Methoden

(11β,16β)-11,21-bis(acetyloxy)-2'-Methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione (Deflazacort IMpurity) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.